{
  "ticker": "BCRX",
  "company_name": "BioCryst Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00035022",
      "title": "Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Leukemia, Lymphocytic, Lymphoma",
      "start_date": "2001-08",
      "completion_date": "2004-03",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT00486980",
      "title": "Intramuscular Peramivir for the Treatment of Uncomplicated Influenza",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Influenza",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT00289549",
      "title": "Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Leukemia, Lymphocytic, Chronic",
      "start_date": "2005-06",
      "completion_date": "2009-01",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT00419263",
      "title": "Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Influenza",
      "start_date": "2007-01",
      "completion_date": "2007-09",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT05741346",
      "title": "Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Paroxysmal Nocturnal Hemoglobinuria",
      "start_date": "2023-01-18",
      "completion_date": "2025-01-31",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT00002237",
      "title": "A Study of Peldesine (BCX-34) in HIV-Infected Patients",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "HIV Infections",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT06100900",
      "title": "Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Paroxysmal Nocturnal Hemoglobinuria",
      "start_date": "2023-10-24",
      "completion_date": "2024-12-11",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT01224795",
      "title": "A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Influenza",
      "start_date": "2010-10",
      "completion_date": "2010-11",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT01265264",
      "title": "Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Gout, Hyperuricemia, Arthritis, Joint Disease",
      "start_date": "2010-12",
      "completion_date": "2013-02",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    },
    {
      "nct_id": "NCT02125162",
      "title": "A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Hereditary Angioedema",
      "start_date": "2014-04",
      "completion_date": "2014-07",
      "enrollment": 0,
      "sponsor": "BioCryst Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1, PHASE2": 2,
      "PHASE3": 10,
      "PHASE2": 19,
      "PHASE1": 15,
      "": 2,
      "PHASE2, PHASE3": 2
    },
    "by_status": {
      "COMPLETED": 35,
      "WITHDRAWN": 2,
      "TERMINATED": 9,
      "APPROVED_FOR_MARKETING": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 2
    },
    "active_trials": 3,
    "completed_trials": 35,
    "conditions": [
      "Acute, Uncomplicated Human Influenza",
      "COVID-19, Yellow Fever",
      "Cancer",
      "Chronic Lymphocytic Leukemia (CLL)",
      "Complement 3 Glomerulopathy, Immunoglobulin A Nephropathy, Membranous Nephropathy",
      "Cough, Sore Throat, Nasal Congestion, Headache, Fever, Seasonal Influenza",
      "Cutaneous T-cell Lymphoma (CTCL),",
      "Diabetic Macular Edema (DME)",
      "Filovirus Infections, Ebola Virus Infection",
      "Gout",
      "Gout, Hyperuricemia, Arthritis, Joint Disease",
      "Gout, Hyperuricemia, Arthritis, Joint Disease, Renal Insufficiency",
      "HIV Infections",
      "Hereditary Angioedema",
      "Hereditary Angioedema (HAE)",
      "Hereditary Angioedema, HAE",
      "Hereditary Angioedema, HAE, Prophylaxis",
      "Hereditary Angioedema, Pediatric",
      "Influenza",
      "Influenza, Renal Failure",
      "Leukemia, Lymphocytic, Chronic",
      "Leukemia, Lymphocytic, Lymphoma",
      "Leukemia, Lymphoma",
      "Leukemia, T-Cell",
      "Lymphoma",
      "Marburg Virus Disease",
      "Netherton Syndrome",
      "Paroxysmal Nocturnal Hemoglobinuria",
      "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
      "Paroxysmal Nocturnal Hemoglobinuria, PNH",
      "Seasonal Influenza, Cough, Sore Throat, Nasal Congestion, Myalgia, Headache, Fatigue"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:02.932263",
    "search_query": "BioCryst Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=BioCryst+Pharmaceuticals,+Inc."
  }
}